CN104232797A - 一种鼠肝炎病毒的复合型检测试剂盒、检测方法及应用 - Google Patents
一种鼠肝炎病毒的复合型检测试剂盒、检测方法及应用 Download PDFInfo
- Publication number
- CN104232797A CN104232797A CN201410510086.2A CN201410510086A CN104232797A CN 104232797 A CN104232797 A CN 104232797A CN 201410510086 A CN201410510086 A CN 201410510086A CN 104232797 A CN104232797 A CN 104232797A
- Authority
- CN
- China
- Prior art keywords
- hepatitis virus
- murine hepatitis
- mouse
- sample
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000711466 Murine hepatitis virus Species 0.000 title claims abstract description 213
- 238000001514 detection method Methods 0.000 title claims abstract description 71
- 239000002131 composite material Substances 0.000 title abstract 5
- 102000036639 antigens Human genes 0.000 claims abstract description 49
- 108091007433 antigens Proteins 0.000 claims abstract description 49
- 238000000034 method Methods 0.000 claims abstract description 40
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 33
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 31
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 31
- 102000004190 Enzymes Human genes 0.000 claims abstract description 26
- 108090000790 Enzymes Proteins 0.000 claims abstract description 26
- 239000000427 antigen Substances 0.000 claims abstract description 24
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 20
- 238000012216 screening Methods 0.000 claims abstract description 7
- 241000975794 Macropodid alphaherpesvirus 1 Species 0.000 claims abstract description 6
- 101710172711 Structural protein Proteins 0.000 claims abstract description 3
- 239000000523 sample Substances 0.000 claims description 228
- 238000012360 testing method Methods 0.000 claims description 84
- 239000013642 negative control Substances 0.000 claims description 61
- 210000004369 blood Anatomy 0.000 claims description 57
- 239000008280 blood Substances 0.000 claims description 57
- 239000013641 positive control Substances 0.000 claims description 49
- 239000000872 buffer Substances 0.000 claims description 32
- 150000001875 compounds Chemical class 0.000 claims description 31
- 238000005516 engineering process Methods 0.000 claims description 28
- 239000008399 tap water Substances 0.000 claims description 26
- 235000020679 tap water Nutrition 0.000 claims description 26
- 239000003153 chemical reaction reagent Substances 0.000 claims description 24
- 210000003296 saliva Anatomy 0.000 claims description 24
- 239000002953 phosphate buffered saline Substances 0.000 claims description 22
- 238000003752 polymerase chain reaction Methods 0.000 claims description 22
- 238000005406 washing Methods 0.000 claims description 22
- 238000002965 ELISA Methods 0.000 claims description 21
- 238000006911 enzymatic reaction Methods 0.000 claims description 20
- 239000000758 substrate Substances 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 17
- 230000008569 process Effects 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 238000013518 transcription Methods 0.000 claims description 12
- 230000035897 transcription Effects 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 239000011248 coating agent Substances 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- 239000003085 diluting agent Substances 0.000 claims description 8
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 8
- 240000003291 Armoracia rusticana Species 0.000 claims description 7
- 238000002203 pretreatment Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 108091028664 Ribonucleotide Proteins 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- 239000012460 protein solution Substances 0.000 claims description 6
- 239000011535 reaction buffer Substances 0.000 claims description 6
- 239000013558 reference substance Substances 0.000 claims description 6
- 239000002336 ribonucleotide Substances 0.000 claims description 6
- 125000002652 ribonucleotide group Chemical group 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 5
- 229910019142 PO4 Inorganic materials 0.000 claims description 5
- 238000000502 dialysis Methods 0.000 claims description 5
- 229960002897 heparin Drugs 0.000 claims description 5
- 229920000669 heparin Polymers 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 239000010452 phosphate Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 4
- 241000581650 Ivesia Species 0.000 claims description 4
- 229940096437 Protein S Drugs 0.000 claims description 4
- 102000029301 Protein S Human genes 0.000 claims description 4
- 101150075200 S-2 gene Proteins 0.000 claims description 4
- 229940098773 bovine serum albumin Drugs 0.000 claims description 4
- 238000007865 diluting Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000003118 sandwich ELISA Methods 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 4
- 241000713869 Moloney murine leukemia virus Species 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 108010088751 Albumins Proteins 0.000 claims description 2
- 102000009027 Albumins Human genes 0.000 claims description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 claims description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 claims description 2
- 238000010353 genetic engineering Methods 0.000 claims description 2
- 239000007974 sodium acetate buffer Substances 0.000 claims description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 2
- 239000012279 sodium borohydride Substances 0.000 claims description 2
- 239000002689 soil Substances 0.000 claims description 2
- 239000003643 water by type Substances 0.000 claims description 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims 2
- 102000053602 DNA Human genes 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 101710160102 Outer membrane protein B Proteins 0.000 claims 1
- 230000003570 biosynthesizing effect Effects 0.000 claims 1
- 238000001631 haemodialysis Methods 0.000 claims 1
- 230000000322 hemodialysis Effects 0.000 claims 1
- 244000000010 microbial pathogen Species 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 102000013415 peroxidase activity proteins Human genes 0.000 claims 1
- 108040007629 peroxidase activity proteins Proteins 0.000 claims 1
- 238000010998 test method Methods 0.000 claims 1
- 238000003757 reverse transcription PCR Methods 0.000 abstract description 31
- 241000699670 Mus sp. Species 0.000 abstract description 10
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 108020004711 Nucleic Acid Probes Proteins 0.000 abstract description 2
- 239000002853 nucleic acid probe Substances 0.000 abstract description 2
- 238000012215 gene cloning Methods 0.000 abstract 1
- 239000003547 immunosorbent Substances 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 190
- 230000001684 chronic effect Effects 0.000 description 36
- 208000015181 infectious disease Diseases 0.000 description 34
- 241000700605 Viruses Species 0.000 description 19
- 230000036737 immune function Effects 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 15
- 238000011579 SCID mouse model Methods 0.000 description 14
- 238000003556 assay Methods 0.000 description 13
- 230000003612 virological effect Effects 0.000 description 12
- 230000002255 enzymatic effect Effects 0.000 description 11
- 238000001228 spectrum Methods 0.000 description 11
- 239000003463 adsorbent Substances 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 5
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 5
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 5
- 231100000283 hepatitis Toxicity 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 4
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 4
- 229910000397 disodium phosphate Inorganic materials 0.000 description 4
- 235000019800 disodium phosphate Nutrition 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 108091092562 ribozyme Proteins 0.000 description 4
- 230000009385 viral infection Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 101710153593 Albumin A Proteins 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 238000008157 ELISA kit Methods 0.000 description 3
- 101100518008 Mus musculus Nxf1 gene Proteins 0.000 description 3
- 208000037581 Persistent Infection Diseases 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 210000002845 virion Anatomy 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- 208000029462 Immunodeficiency disease Diseases 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 2
- 108010061100 Nucleoproteins Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 229960004676 antithrombotic agent Drugs 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000007813 immunodeficiency Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- 108700016947 Bos taurus structural-GP Proteins 0.000 description 1
- 102100031673 Corneodesmosin Human genes 0.000 description 1
- 101710139375 Corneodesmosin Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 108050005735 Maltoporin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000008906 Murine coronavirus Species 0.000 description 1
- 241000711495 Murine hepatitis virus strain S Species 0.000 description 1
- 101710116435 Outer membrane protein Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108010066124 Protein S Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000018210 Recoverin Human genes 0.000 description 1
- 108010076570 Recoverin Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 101710198474 Spike protein Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005101 cell tropism Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 201000002491 encephalomyelitis Diseases 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000036438 mutation frequency Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000005570 vertical transmission Effects 0.000 description 1
- 239000000277 virosome Substances 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410510086.2A CN104232797B (zh) | 2014-09-28 | 2014-09-28 | 一种鼠肝炎病毒的复合型检测试剂盒、检测方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410510086.2A CN104232797B (zh) | 2014-09-28 | 2014-09-28 | 一种鼠肝炎病毒的复合型检测试剂盒、检测方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104232797A true CN104232797A (zh) | 2014-12-24 |
CN104232797B CN104232797B (zh) | 2016-03-02 |
Family
ID=52221687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410510086.2A Active CN104232797B (zh) | 2014-09-28 | 2014-09-28 | 一种鼠肝炎病毒的复合型检测试剂盒、检测方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104232797B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111316100A (zh) * | 2017-09-12 | 2020-06-19 | H·路德维希 | 检测急性博尔纳病病毒(bdv)感染的方法及其诊断试剂盒,特别是组合区分急性及慢性和潜伏性bdv感染的方法及其诊断试剂盒 |
CN112048566A (zh) * | 2020-09-29 | 2020-12-08 | 山东绿都生物科技有限公司 | 同时检测鸡毒支原体和鸡滑液囊支原体的产品、方法与应用 |
CN113151359A (zh) * | 2020-12-25 | 2021-07-23 | 广州医科大学 | 一种冠状病毒的缺陷型嵌合病毒模型的包装体系及其应用 |
CN113913552A (zh) * | 2021-09-28 | 2022-01-11 | 锦州医科大学 | 小鼠肝炎病毒实时荧光rt-rpa检测的引物和探针、试剂盒及检测方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013101783A2 (en) * | 2011-12-30 | 2013-07-04 | Bio-Rad Laboratories, Inc. | Methods and compositions for performing nucleic acid amplification reactions |
-
2014
- 2014-09-28 CN CN201410510086.2A patent/CN104232797B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013101783A2 (en) * | 2011-12-30 | 2013-07-04 | Bio-Rad Laboratories, Inc. | Methods and compositions for performing nucleic acid amplification reactions |
Non-Patent Citations (2)
Title |
---|
赖国旗等: "小鼠肝炎病毒RT-PCR检测方法的研究", 《西南农业大学学报(自然科学版)》 * |
郭玮等: "小鼠肝炎病毒抗体检测试剂盒的标准化研究", 《中国实验动物学报》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111316100A (zh) * | 2017-09-12 | 2020-06-19 | H·路德维希 | 检测急性博尔纳病病毒(bdv)感染的方法及其诊断试剂盒,特别是组合区分急性及慢性和潜伏性bdv感染的方法及其诊断试剂盒 |
CN111316100B (zh) * | 2017-09-12 | 2024-04-16 | H·路德维希 | 检测急性博尔纳病病毒(bdv)感染的方法及其诊断试剂盒,特别是组合区分急性及慢性和潜伏性bdv感染的方法及其诊断试剂盒 |
CN112048566A (zh) * | 2020-09-29 | 2020-12-08 | 山东绿都生物科技有限公司 | 同时检测鸡毒支原体和鸡滑液囊支原体的产品、方法与应用 |
CN113151359A (zh) * | 2020-12-25 | 2021-07-23 | 广州医科大学 | 一种冠状病毒的缺陷型嵌合病毒模型的包装体系及其应用 |
CN113913552A (zh) * | 2021-09-28 | 2022-01-11 | 锦州医科大学 | 小鼠肝炎病毒实时荧光rt-rpa检测的引物和探针、试剂盒及检测方法 |
CN113913552B (zh) * | 2021-09-28 | 2024-02-20 | 锦州医科大学 | 小鼠肝炎病毒实时荧光rt-rpa检测的引物和探针、试剂盒及检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104232797B (zh) | 2016-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111537742B (zh) | 可用于检测新型冠状病毒的中和抗体的检测试剂盒 | |
CN104232797B (zh) | 一种鼠肝炎病毒的复合型检测试剂盒、检测方法及应用 | |
JP4278174B2 (ja) | Hiv−1のoグループ(またはサブグループ)レトロウイルス性抗原のヌクレオチド配列 | |
CN110221065B (zh) | 一种禽滑液囊支原体间接elisa检测试剂盒 | |
CN106518990B (zh) | 一种寨卡病毒抗原及其应用 | |
CN108680744B (zh) | 一种检测新型鸭呼肠孤病毒抗体的间接elisa检测试剂盒及应用 | |
CN105973854B (zh) | 一种基于f2蛋白的检测4型禽腺病毒抗体的间接免疫荧光试剂盒 | |
Dominguez et al. | Isolation, propagation, genome analysis and epidemiology of HKU1 betacoronaviruses | |
TW201300421A (zh) | 用於偵測豬繁殖及呼吸道綜合症病毒(prrsv)之試劑及方法 | |
JP3095219B2 (ja) | LAVに対する抗体と反応性であるgagによりコードされたペプチド及びその使用 | |
CN109402069A (zh) | 一种假病毒颗粒及其制备方法和应用 | |
CN108956985B (zh) | 一种检测新型鹅星状病毒抗体的间接elisa检测试剂盒及应用 | |
CN112920268B (zh) | ASFV-p54蛋白特异性的纳米抗体-HRP融合蛋白及制备方法、应用 | |
CN102023212A (zh) | 一种流感病毒神经氨酸酶抗体的快速检测方法 | |
CN106497884A (zh) | 一种重组hek‑293t细胞及其分泌寨卡病毒非结构蛋白1 | |
CN113817753A (zh) | 表达SARS-CoV-2纤突蛋白或其变异体SΔ21的假型化VSV病毒构建和应用 | |
US20100297604A1 (en) | Methods and reagents for virus isolation and detection | |
CN106018780B (zh) | 一种基于f1蛋白的检测4型禽腺病毒抗体的间接免疫荧光试剂盒 | |
CN108693357B (zh) | 一种检测新型鸡呼肠孤病毒抗体的间接elisa检测试剂盒及应用 | |
US20140128447A1 (en) | Novel non-primate hepacivirus | |
CN104497109B (zh) | 一种检测流行性乙型脑炎病毒抗体的重组抗原蛋白及试剂盒 | |
CN104745604B (zh) | 猪细小病毒液相芯片检测试剂盒 | |
CN107664694A (zh) | 一种基于e2蛋白检测猪非典型瘟病毒抗体的elisa试剂盒 | |
CN106198974A (zh) | 一种快速检测虹鳟鱼血清中ihnv抗体的elisa检测试剂盒 | |
JPH09504685A (ja) | Hardsウイルスの組換えdna抗原を製造する分子クローン |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 430075, D1 building, Optics Valley biological city innovation park, 666 hi tech Avenue, Hubei, Wuhan Applicant after: The biomedical company limited in Cologne, Wuhan Address before: 430075 Hubei city of Wuhan province high tech Road No. 666 Optics Valley city biological innovation park building B1 C207 Applicant before: The biomedical company limited in Cologne, Wuhan |
|
CB03 | Change of inventor or designer information |
Inventor after: Feng Xiang Inventor after: Shi Jianfang Inventor after: Gao Zhongxiang Inventor after: Tang Lijun Inventor after: Li Yanmei Inventor after: Jia Ziming Inventor before: Feng Xiang Inventor before: Shi Jianfang Inventor before: Gao Zhongxiang Inventor before: Tang Lijun Inventor before: Li Yanmei Inventor before: Jia Zhiming |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201116 Address after: 430000 301 building B, No.17 Jiangxing Road, Jianghan District, Wuhan City, Hubei Province Patentee after: Gao Zhongxiang Address before: 430075, D1 building, Optics Valley biological city innovation park, 666 hi tech Avenue, Hubei, Wuhan Patentee before: WUHAN CLONE BIOMEDICAL Co.,Ltd. |
|
TR01 | Transfer of patent right |